Lexaria Bioscience Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
31 Aug 24 | BuyUS$322,428 | Wayne Boos | Individual | 113,531 | US$2.84 | |
31 Aug 24 | SellUS$1,691,293 | Wayne Boos | Individual | 533,531 | US$3.17 | |
12 Aug 24 | BuyUS$5,008 | Catherine Turkel | Individual | 1,600 | US$3.13 | |
31 Jul 24 | BuyUS$391,162 | Wayne Boos | Individual | 137,733 | US$2.84 | |
31 Jul 24 | SellUS$10,268 | Vanessa Carle | Individual | 2,567 | US$4.00 | |
31 Jul 24 | SellUS$751,155 | Wayne Boos | Individual | 242,308 | US$3.10 | |
31 Mar 24 | BuyUS$1,707,881 | Wayne Boos | Individual | 563,657 | US$3.03 | |
31 Mar 24 | SellUS$114,289 | Wayne Boos | Individual | 53,657 | US$2.13 | |
31 Dec 23 | BuyUS$126,504 | Wayne Boos | Individual | 90,000 | US$1.41 | |
31 Dec 23 | SellUS$39,300 | Wayne Boos | Individual | 30,000 | US$1.31 |
Insider Trading Volume
Insider Buying: LEXX insiders have sold more shares than they have bought in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 308,487 | 1.77% |
Institutions | 1,063,064 | 6.09% |
Individual Insiders | 1,391,050 | 7.97% |
General Public | 14,689,993 | 84.2% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 69.8%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
600,000 | US$1.3m | -41.2% | no data | |||
475,773 | US$994.4k | -7.36% | 0.14% | |||
468,382 | US$978.9k | 0% | no data | |||
273,543 | US$571.7k | 0% | no data | |||
254,412 | US$531.7k | 0% | no data | |||
150,391 | US$314.3k | 31% | no data | |||
109,022 | US$227.9k | 16.5% | no data | |||
60,000 | US$125.4k | 0% | 0.01% | |||
54,075 | US$113.0k | 0% | no data | |||
44,900 | US$93.8k | -7.99% | no data | |||
39,301 | US$82.1k | 0% | no data | |||
27,445 | US$57.4k | 0% | no data | |||
24,000 | US$50.2k | 0% | no data | |||
22,982 | US$48.0k | 0% | no data | |||
18,626 | US$38.9k | 47.8% | no data | |||
18,389 | US$38.4k | 0% | no data | |||
14,000 | US$29.3k | 0% | no data | |||
13,823 | US$28.9k | 0% | no data | |||
13,191 | US$27.6k | 0% | no data | |||
13,023 | US$27.2k | 0% | no data | |||
11,000 | US$23.0k | 0% | no data | |||
10,917 | US$22.8k | 0% | no data | |||
10,917 | US$22.8k | 0% | no data | |||
10,257 | US$21.4k | 0% | no data | |||
7,283 | US$15.2k | 0% | no data |